IRP strategy simulator, powered by Flexi-IPRTM

Providing evidence-based international reference pricing simulators to the pharmaceutical industry

Inpharmation’s international reference pricing simulators have been developed over two decades, specifically for the strategic analysis requirements of global pharma pricing and market access teams. Because 7 of the top-10 countries, ranked by pharmaceutical sales, use IRP as part of the pricing and reimbursement agreement process, no pricing strategy can ignore the impact of reference pricing.

Inpharmation is the leading provider of strategic international pricing solutions for the pharma industry; all IRP strategy simulators are built upon a wealth of expert knowledge and a solid evidence-base:

  • All IRP strategy simulators include access to detailed international reference pricing rules database covering a system of >90 countries to make sure your forecasts are based on full-system data.
  • Fully comprehensive international reference pricing simulations built into all launch optimization modules with average real-world revenue improvement recommendations of 2.5%.*
  • The majority of the top-20 pharma industry already use Inpharmation’s international reference pricing solutions to run strategic price forecasts.
*Inpharmation-recommended revenue improvements n=33
>
Scale of countries included in the international price referencing database included in your Flexi-IPR subscription.

Inpharmation’s international reference pricing software scales and fits to the requirements of your pricing and market access environment:
  • An effective solution: The accuracy of your international pricing forecasts is based upon the quality of your market knowledge. Inpharmation provide access to a truly global reference pricing rules database with over 3540 bits of reference pricing information. Not only that, but as changes to the system occur, the quality of your strategy simulator is maintained with included software updates.
  • A low-risk solution: Because it has evolved over decades to meet the requirements of the majority of the top-50 global pharma industry.
  • The most adaptable solution: Inpharmation’s IRP strategy simulators are incredibly scalable; currently in use by the largest pricing and market access teams, with >30 users and can integrate the inputs of 100 affiliate countries with 500 different user inputs. At the same time our customized solutions help the smallest pricing and market access teams, with a single member, manage brand pricing strategy for a whole portfolio of products.
  • An integrated solution: Because the international reference pricing simulator can easily hook up to any existing pricing, forecasting and exchange rate databases that you may have, we make sure that your time is free to think about your pricing strategy, not software maintenance.
  • A team-centred solution: When global and regional pricing and market access teams need affiliate input, Inpharmation’s cloud-based solution, Cloud-SheetsTM can integrate the knowledge of 100 affiliate countries in a single click.
%
Scale of average real-world recommended revenue improvements from launch sequence optimization module.*

“Inpharmation's approach to IPR offers an intuitive and comprehensive approach to modelling the complexities of the IPR environment. Their tool enables rapid "what-if" scenario analyses that simply could not be investigated without such a tool.
From the results we have been able to develop a number of informed strategies that have significantly reduced the impact of price erosions across Europe.”

Director Trade and Pricing, Top-20 pharmaceutical company

Evidence-based international reference pricing

For the past two decades, Inpharmation has championed an approach to strategic international reference pricing analysis that is built upon a solid evidence-base. This means that all Inpharmation’s reference pricing solutions are based upon:

  • The latest international and internal reference pricing methodologies being actively applied.
  • Independently-sourced reference pricing data, with direct inputs from national health agencies where available.
  • Principles that are actively being applied to minimize price erosion in the real-wold forecasts for top-50 pharma companies.

Included in all Inpharmation’s international pricing project deliverables is delivery and training from Inpharmation; leaders in passing on our knowledge to our customers, in fact 91% of pricing and market access course attendees highly rate our forecasting training.

Download the full Case Study by filling in the form:
Scroll Top